Table 4 Patients with idiopathic diabetes divided in groups A (patients who continued insulin after 12 months from the disease onset) and B (patients who suspended insulin after 12 months from the disease onset)
|  | Group A (N = 12) | Group B (N = 18) | p* |
|---|---|---|---|
Mean ± SD | Mean ± SD | ||
Clinical parameters | |||
 Age of onset | 31.3 ± 7.31 | 26.8 ± 10.7 | 0.220 |
 BMI (kg/m2) | 25.7 ± 3.01 | 24.9 ± 3.31 | 0.529 |
 WC (cm) | 97.4 ± 11.3 | 97.3 ± 9.8 | 0.994 |
 SBP (mmHg) | 112.9 ± 14.9 | 112.6 ± 8.83 | 0.953 |
 DBP (mmHg) | 69.6 ± 9.14 | 67 ± 9.84 | 0.461 |
 VAI | 1.09 ± 0.22 | 1.71 ± 0.34 | < 0.001 |
Metabolic parameters | |||
 HDL-cholesterol (mmol/l) | 1.01 ± 0.31 | 0.98 ± 0.08 | 0.540 |
 Triglycerides (mmol/l) | 0.77 ± 0.11 | 0.98 ± 0.27 | 0.017 |
 LDL-cholesterol (mmol/l) | 3.41 ± 0.67 | 3.52 ± 0.81 | 0.689 |
 Total-cholesterol (mmol/l) | 4.78 ± 0.67 | 4.96 ± 0.85 | 0.529 |
 GOT (U/l) | 25.5 ± 10.4 | 19.8 ± 6.60 | 0.082 |
 GPT (U/l) | 25.9 ± 9.63 | 19.3 ± 9.35 | 0.075 |
 Glycaemia (mmol/l) | 7.47 ± 0.90 | 6.95 ± 1.01 | 0.156 |
 HbA1c (%) | 8.01 ± 1.26 | 8.56 ± 1.09 | 0.216 |
 Insulin requirement (U/kg) | 0.57 ± 0.10 | 0.46 ± 0.22 | 0.129 |
Insulin Sensitivity Index | |||
 M value | 3.4 ± 1.03 | 2.63 ± 1.12 | 0.071 |